|
Volumn 13, Issue 5, 2002, Pages 497-503
|
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer
a a a a a a a a a a a |
Author keywords
5 Fluorouracil; Cisplatin; Folinic acid; Gastric cancer; Paclitaxel; Phase II
|
Indexed keywords
ANTIEMETIC AGENT;
CISPLATIN;
DEXAMETHASONE;
DOXORUBICIN;
FLUOROURACIL;
FOLINIC ACID;
METHOTREXATE;
PACLITAXEL;
PYRIDOXINE;
RANITIDINE;
ANTINEOPLASTIC AGENT;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ANEMIA;
ARTICLE;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DIARRHEA;
DRUG EFFICACY;
FEMALE;
HAND FOOT SYNDROME;
HUMAN;
INFECTION;
LEUKOPENIA;
MALE;
NAUSEA;
NEUROTOXICITY;
OUTPATIENT CARE;
PERIPHERAL NEUROPATHY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
STOMACH ADENOCARCINOMA;
STOMACH CANCER;
VOMITING;
ADENOCARCINOMA;
ADJUVANT CHEMOTHERAPY;
CHEMICALLY INDUCED DISORDER;
DRUG ADMINISTRATION;
FOLLOW UP;
GASTROINTESTINAL DISEASE;
HEMATOLOGIC DISEASE;
LYMPH NODE METASTASIS;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
STOMACH TUMOR;
SURVIVAL RATE;
TIME;
ADENOCARCINOMA;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
GASTROINTESTINAL DISEASES;
HEMATOLOGIC DISEASES;
HUMAN;
LEUCOVORIN;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGE;
PACLITAXEL;
STOMACH NEOPLASMS;
SURVIVAL RATE;
TIME FACTORS;
HUMANS;
MIDDLE AGED;
|
EID: 0035987101
PISSN: 09594973
EISSN: None
Source Type: Journal
DOI: 10.1097/00001813-200206000-00008 Document Type: Article |
Times cited : (59)
|
References (38)
|